"10.1371_journal.pone.0137560","plos one","2015-10-28T00:00:00Z","T N A van den Berg; S El Messaoudi; G A Rongen; P H H van den Broek; A Bilos; A R T Donders; M E Gomes; N P Riksen","Department of Pharmacology-Toxicology, Radboud university medical center, Nijmegen, The Netherlands; Department of Internal Medicine (division of vascular medicine), Radboud university medical center, Nijmegen, The Netherlands; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands; Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands","Conceived and designed the experiments: GAR MEG NPR. Performed the experiments: TNAvdB SEM PHHvdB AB. Analyzed the data: SEM TNAvdB ARTD. Contributed reagents/materials/analysis tools: PHHvdB AB. Wrote the paper: SEM TNAvdB ARTD NPR MEG GAR PHHvdB AB.","The study is conducted with financial support from AstraZeneca. NPR and MEG have served on a scientific advisory board of AstraZeneca. GAR has served on a scientific advisory board of Novartis. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","10","T N A van den Berg","TNAVDB",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
